Boone Capital Management LLC
Annual return '25
+17.2%
SPY '25
+17.7%
Alpha
-0.5ptsvs SPY
Invested
$652.8M
Holdings
13
Trades YTD
0
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsIn development
Quarterly performance not yet computed for this fund.
The metrics pipeline computes return / SPY benchmark / alpha per quarter from this fund's 13F holdings and the SPY adj-close. It hasn't produced enough quarters here yet — the chart fills in automatically once at least two are on record.
Top holdings · current snapshot
Source: 13F-HR01
$MIRM
MIRUM PHARMACEUTICALS INC
Q3 2025: Sold 16.5% (641.4k → 535.7k shares)
13.0%
02
$IONS
IONIS PHARMACEUTICALS INC
Q3 2025: New position (417.8k shares)
12.6%
03
$CI
THE CIGNA GROUP
Q3 2025: Increased +133.1% (35.6k → 83.0k shares)
12.3%
04
$TFX
TELEFLEX INCORPORATED
Held since at least Q1 2024
11.2%
05
$BMRN
BIOMARIN PHARMACEUTICAL INC
Q3 2025: Sold 26.6% (447.4k → 328.5k shares)
10.4%
06
$GRDN
GUARDIAN PHARMACY SVCS INC
Held since at least Q1 2024
8.0%
07
$UNH
UNITEDHEALTH GROUP INC
Q2 2025: New position (58.1k shares)
7.2%
08
$MDT
MEDTRONIC PLC
Q2 2025: Increased +8.9% (393.7k → 428.8k shares)
5.8%
09
$BBIO
BRIDGEBIO PHARMA INC
Q3 2025: New position (460.3k shares)
5.7%
10
$AVNS
AVANOS MED INC
Held since at least Q1 2024
5.6%
Recent trades · Last 90 days
No Form 4 / 13D / 13G trade events on file in the recent window. 13F filers report position snapshots quarterly rather than per-trade events, so this section is most useful for managers who also file Form 4 or 13D/G.
Source data: SEC EDGAR · 13F-HR filings · Performance through 2025-12-31 · Last refreshed 12:02 UTC.